Inhibition of ADAM8 and MMP activity impedes the invasive and migratory capabilities of drug-resistant CRC cells, suggesting that ADAM8 may serve as a macrophage-related biomarker in CRC, warranting further investigation 118. The gene discussed is ADAM8; the disease is colorectal carcinoma.